MedTrace Logo

A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)

NCT00705289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 728

Last updated 2015-07-30

Study results available
· View outcomes & findings →

Summary

This 14-week non-interventional study will observe patients with rheumatoid arthritis (RA) who are being treated with infliximab for the first time, in order to learn about their disease characteristics. Patients in this study will be treated for RA with infliximab and in a usual manner as decided by their physician.

Conditions

Interventions

BIOLOGICAL

Infliximab

Infliximab used in line with current clinical practice and local guidelines.

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2008-09-30
Completion
2008-09-30

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00705289 on ClinicalTrials.gov